US4330001060
© BusinessWire
10.12.2025
HIMS
LISTED
NYSE
Hims & Hers Brings Comprehensive Weight Loss Programme to the UK
News Preview
Hims & Hers is deepening its commitment to the UK by bringing access to its comprehensive Weight Loss Programme to customers. This expansion includes the official introduction of the Hers platform, helping eligible women across the UK receive access to this holistic weight management care.
This press release features multimedia. View the full...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
HIMS
LISTED
NYSE
Hims & Hers Now Serving Customers in Canada
News Preview
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform in the United States, is now serving customers in Canada. This entry follows the recent acquisition of Livewell, a trusted Canadian digital health platform focused on weight loss. Through this expansion, Hims & Hers is well-positioned to usher in the next era o...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
HIMS
LISTED
NYSE
Hims & Hers Continues Major International Expansion With Official Entry Into Canada
News Preview
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform in the United States, is now serving customers in Canada. This entry follows the recent completion of Hims & Hers’ acquisition of Livewell, a trusted Canadian digital health platform offering access to a variety of treatments, with a focus on weight loss. Build...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
03.12.2025
HIMS
LISTED
NYSE
Hims & Hers to Acquire YourBio Health, Pioneer Behind Advanced, Pain-Free Blood Sampling Technology
News Preview
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced that it has entered into a definitive agreement to acquire YourBio Health, Inc., a Boston-based pioneer in capillary whole blood sampling technology. Powered by YourBio’s advanced blood sampling devices, the acquisition will help accelerate efforts...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
17.11.2025
HIMS
LISTED
NYSE
Hims & Hers Health, Inc. Announces $250 Million Share Repurchase Program Authorization
News Preview
Hims & Hers Health, Inc. (“Hims & Hers” or the “Company,” NYSE: HIMS), the leading health and wellness platform, today announced that its Board of Directors has authorized a share repurchase program of up to $250 million of outstanding Class A common stock over the next three years. This new program follows the successful completion of the...
Themefolio
Profiler
Peergroup
© BusinessWire
17.11.2025
HIMS
LISTED
NYSE
Hims & Hers Names Deb Autor as Chief Policy Officer to Lead Global Policy and Regulatory Strategy
News Preview
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Deb Autor as the company’s first Chief Policy Officer. In this new role, Autor will collaborate with other stakeholders, including consumers, telehealth platforms, providers, advocacy groups, medical associations, pharmaceutical...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
HIMS
LISTED
NYSE
Hims & Hers Introduces Labs, a Holistic, In-Depth Testing Experience That Puts Customers in Control of Their Health and Wellness Journeys
News Preview
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of Labs, a new way for customers to understand their overall health and identify ways to improve and maintain it. Labs measures key markers over time and provides doctor-developed action plans that can power real shifts in health outcome...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
HIMS
LISTED
NYSE
Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results
News Preview
Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the third quarter ended September 30, 2025, in a shareholder letter that is posted at investors.hims.com.
“This quarter we continued to prove that our vision of helping tens of millions of...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
HIMS
LISTED
NYSE
Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026
News Preview
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of a new specialty in women’s health, offering access to affordable treatment plans built specifically for women experiencing perimenopause and menopause. Starting today, women can work with a provider on the platform to access treatment...
Themefolio
Profiler
Peergroup
© BusinessWire
13.10.2025
HIMS
LISTED
NYSE
Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025
News Preview
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report third quarter 2025 financial results after the market closes on Monday, November 3, 2025. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.
The conference call...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
HIMS
LISTED
NYSE
Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor’s Office
News Preview
Hims & Hers Health, Inc. (NYSE: HIMS) today published a new white paper - Understanding Hims & Hers Approach to Clinical Excellence, Quality, and Safety - detailing how rigorous standards, continuous monitoring, and customer-centered design are shaping the future of safe and effective telehealth.
“At Hims & Hers, we believe that digi...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
HIMS
LISTED
NYSE
Hims Launches New Category in Men’s Health with Exclusive Branded Oral Testosterone and Expanded Personalized Treatments
News Preview
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of a new category in men’s health, offering access to innovative, affordable, and personalized treatment plans for low testosterone.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/h...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
25.08.2025
HIMS
LISTED
NYSE
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) and reminds investors of the August 25, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faru...
Themefolio
Profiler
Peergroup
© BusinessWire
22.08.2025
HIMS
LISTED
NYSE
HIMS & HERS HEALTH 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS
News Preview
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS), if they purchased the Company’...
Themefolio
Profiler
Peergroup
© BusinessWire
29.07.2025
HIMS
LISTED
NYSE
Hims & Hers Data Shows Personalized GLP-1 Plans Drive Real Weight Loss, Few Side Effects, and Strong Adherence to Care
News Preview
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today released new data showing that its personalized, digital-first approach to weight loss is driving meaningful, sustainable results, laying the groundwork for lasting success. In a first-of-its-kind U.S. analysis of treatment plans, includin...
Themefolio
Profiler
Peergroup
© BusinessWire
14.07.2025
HIMS
LISTED
NYSE
Hims & Hers to Announce Second Quarter 2025 Financial Results on August 4, 2025
News Preview
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter 2025 financial results after the market closes on Monday, August 4, 2025. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.
The conference call...
Themefolio
Profiler
Peergroup
© BusinessWire
11.07.2025
HIMS
LISTED
NYSE
Kirby McInerney LLP Reminds Hims & Hers Health, Inc. (HIMS) Investors of Class Action Filing and Encourages Investors to Contact the Firm
News Preview
The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS) securities during the period of April 29, 2025, through June 23, 2025, inc...
Themefolio
Profiler
Peergroup
© BusinessWire
09.07.2025
HIMS
LISTED
NYSE
Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion
News Preview
Hims & Hers Health, Inc. (NYSE: HIMS) the leading digital health and wellness platform, today announced its plans to bring its affordable, holistic weight loss program to Canada, timed with the anticipated first-ever availability of generic semaglutide anywhere in the world. This move follows the recent closing of the company's acquisition of...
Themefolio
Profiler
Peergroup
© BusinessWire
30.06.2025
HIMS
LISTED
NYSE
Deadline Approaching: Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Urged to Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming August 25, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, inclusive (the “Class Period”).
IF YOU ARE AN INV...
Themefolio
Profiler
Peergroup
© BusinessWire
27.06.2025
HIMS
LISTED
NYSE
Deadline Alert: Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming August 25, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) securities between April 29, 2025 and June 22, 2025, inclusive (the “Clas...
Themefolio
Profiler
Peergroup
© BusinessWire
27.06.2025
HIMS
LISTED
NYSE
HIMS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, both dates inclusive (the “Class Period”), have until August 25, 2025 to seek appointment as lead plaintiff of the Hims & Hers class action lawsuit. Captio...
Themefolio
Profiler
Peergroup
© BusinessWire
27.06.2025
HIMS
LISTED
NYSE
Hims & Hers Health, Inc. (NYSE: HIMS) Accused of “Illegal Mass Compounding and Deceptive Marketing” Practices; Investors Urged to Contact Award-Winning Firm, Gibbs Mura
News Preview
Gibbs Mura announces that on June 25, 2025, a lawsuit was filed against Hims & Hers Health, Inc. (“Hims and Hers”) on behalf of investors who purchased or acquired Hims & Hers securities between April 29, 2025, and June 23, 2025. Shares of Hims & Hers previously fell over 33% in intraday trading on Monday, June 23, 2025, after Novo Nor...
Themefolio
Profiler
Peergroup
© BusinessWire
26.06.2025
HIMS
LISTED
NYSE
HIMS & HERS HEALTH SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS
News Preview
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS), if they purchased the Company’s se...
Themefolio
Profiler
Peergroup
© BusinessWire
26.06.2025
HIMS
LISTED
NYSE
HIMS BREAKING NEWS: A Class Action Lawsuit has been filed against Hims & Hers Health, Inc. -- Investors are Notified to Contact BFA Law to Potentially Recover Investment Losses
News Preview
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company’s senior executives for potential violations of the federal securities laws.
If you invested in Hims & Hers, you are encouraged to obtain additional information by vis...
Themefolio
Profiler
Peergroup
© BusinessWire
26.06.2025
HIMS
LISTED
NYSE
Law Offices of Howard G. Smith Encourages Hims & Hers Health, Inc. (HIMS) Investors To Inquire About Securities Fraud Class Action
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) securities between April 29, 2025 and June 22, 2025, inclusive (the “Class Period”). Hims investors have until August 25, 2025 to file a lead plaintiff motion....
Themefolio
Profiler
Peergroup
© BusinessWire
26.06.2025
HIMS
LISTED
NYSE
NYSE: HIMS: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Class Action Lawsuit Against Hims & Hers Health, Inc. (HIMS)
News Preview
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS) on behalf of those who purchased or otherwise acquired Hims & Hers securities between April 29, 2025, and June 23, 2025, inclusive (t...
Themefolio
Profiler
Peergroup
© BusinessWire
26.06.2025
HIMS
LISTED
NYSE
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Hims & Hers Health, Inc. (“Hims & Hers” or “the Company”) (NYSE: HIMS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange C...
Themefolio
Profiler
Peergroup
© BusinessWire
26.06.2025
HIMS
LISTED
NYSE
Law Offices of Frank R. Cruz Encourages Hims & Hers Health, Inc. (HIMS) Investors To Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) securities between April 29, 2025 and June 22, 2025, inclusive (the “Class Period”). Hims investors have until August 25, 2025 to file a lead plaintiff motion...
Themefolio
Profiler
Peergroup
© BusinessWire
26.06.2025
HIMS
LISTED
NYSE
Rosen Law Firm Urges Hims & Hers Health, Inc. (NYSE: HIMS) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025. Hims describes itself as a “U.S.-based telehealth company that offers online access to health consultations and treatment...
Themefolio
Profiler
Peergroup
© BusinessWire
26.06.2025
HIMS
LISTED
NYSE
HIMS CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Hims & Hers Health, Inc.
News Preview
The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Northern District of California, captioned Sookdeo v. Hims & Hers Health, Inc., et al., Case No. 3:25-cv-05315, on behalf of persons and entities that purchased or otherwise acquired Hims & Hers Health, Inc. (“Him...
Themefolio
Profiler
Peergroup
© BusinessWire
26.06.2025
HIMS
LISTED
NYSE
HIMS CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit on Behalf of Hims & Hers Health, Inc. Investors
News Preview
Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Northern District of California, captioned Sookdeo v. Hims & Hers Health, Inc., et al., Case No. 3:25-cv-05315, on behalf of persons and entities that purchased or otherwise acquired Hims & Hers Health, In...
Themefolio
Profiler
Peergroup
© BusinessWire
24.06.2025
HIMS
LISTED
NYSE
HIMS INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Launches Investigation into Hims & Hers Health, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact Law Firm
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Hims & Hers Health, Inc. (NYSE: HIMS) focused on whether Hims & Hers and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors.
If...
Themefolio
Profiler
Peergroup
© BusinessWire
24.06.2025
HIMS
LISTED
NYSE
Johnson Fistel Investigates Hims & Hers Regulatory Evasion and Investor Impact
News Preview
Johnson Fistel, PLLP announces that it is investigating potential claims on behalf of investors of Hims & Hers Health, Inc. (NYSE: HIMS) regarding possible violations of federal securities laws. Investors who purchased Hims & Hers securities may be eligible to recover losses stemming from alleged misrepresentations and omissions made by th...
Themefolio
Profiler
Peergroup
© BusinessWire
24.06.2025
HIMS
LISTED
NYSE
Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON HI...
Themefolio
Profiler
Peergroup
© BusinessWire
24.06.2025
HIMS
LISTED
NYSE
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation With the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. (“Hims & Hers” or “the Company”) (NYSE: HIMS) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements an...
Themefolio
Profiler
Peergroup
© BusinessWire
24.06.2025
HIMS
LISTED
NYSE
HIMS & HERS HEALTH INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims on Behalf of Investors of Hims & Hers Health, Inc. - HIMS
News Preview
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), is investigating claims on behalf of investors of Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS).
The investigation concerns whether Hims & Hers Health and certain of its officers and/or dire...
Themefolio
Profiler
Peergroup
© BusinessWire
23.06.2025
HIMS
LISTED
NYSE
HIMS BREAKING NEWS: Hims & Hers Health, Inc. is being Investigated for Securities Fraud; Investors with Losses are Notified to Contact BFA Law
News Preview
Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Hims & Hers Health, Inc. (NYSE: HIMS) for potential violations of the federal securities laws.
If you invested in Hims & Hers, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/hims-hers-he...
Themefolio
Profiler
Peergroup
© BusinessWire
23.06.2025
HIMS
LISTED
NYSE
Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN HIMS & HERS HEALTH, INC. (HIMS), CONTACT THE LAW OFFICES OF HOWARD G. SMITH...
Themefolio
Profiler
Peergroup
© BusinessWire
23.06.2025
HIMS
LISTED
NYSE
Hims & Hers Health, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – HIMS
News Preview
The DJS Law Group announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. (“Hims & Hers” or “the Company”) (NYSE: HIMS) for violations of the securities laws.
INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pert...
Themefolio
Profiler
Peergroup
© BusinessWire
23.06.2025
HIMS
LISTED
NYSE
Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON HIMS & HERS HEALTH, INC. (HIMS), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PU...
Themefolio
Profiler
Peergroup
© BusinessWire
23.06.2025
HIMS
LISTED
NYSE
NYSE: HIMS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors with Significant Losses to Contact the Firm
News Preview
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Hims & Hers Health, Inc. (NYSE: HIMS) (“Hims & Hers”).
On June 23, 2025, during pre-market hours, the pharmaceutical company Novo Nordisk announced it would no long...
Themefolio
Profiler
Peergroup
© BusinessWire
23.06.2025
HIMS
LISTED
NYSE
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds o...
Themefolio
Profiler
Peergroup
© BusinessWire
23.06.2025
HIMS
LISTED
NYSE
Rosen Law Firm Encourages Hims & Hers Health, Inc. Investors to Inquire About Securities Class Action Investigation – HIMS
News Preview
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Hims & Hers Health, Inc. (NYSE: HIMS) resulting from allegations that Hims & Hers may have issued materially misleading business information to the investing public.
So What: If you purchased Hims...
Themefolio
Profiler
Peergroup
© BusinessWire
03.06.2025
HIMS
LISTED
NYSE
Hims & Hers Announces Plans to Acquire ZAVA, Accelerating Major European Growth Across the UK, Germany, France, and Ireland
News Preview
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced a significant step in its global expansion through its agreement to acquire ZAVA, a leading digital health platform in Europe. This strategic move will expand Hims & Hers' footprint in the United Kingdom and will officially launch the company i...
Themefolio
Profiler
Peergroup
© BusinessWire
22.05.2025
HIMS
LISTED
NYSE
Hims & Hers Introduces 6-Month Wegovy® New Customer Offer
News Preview
Hims & Hers Health, Inc. (NYSE: HIMS) today announced eligible customers can access 6 months of prescription-only Wegovy® at a new, affordable price, making proven obesity care and treatments more accessible, more affordable, and more connected for millions of Americans.
This press release features multimedia. View the full release here: https...
Themefolio
Profiler
Peergroup
© BusinessWire
09.05.2025
HIMS
LISTED
NYSE
Hims & Hers Health, Inc. Prices Upsized $870.0 Million Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare
News Preview
Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS) today announced the pricing of its offering of $870,000,000 aggregate principal amount of 0.00% convertible senior notes due 2030 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Secur...
Themefolio
Profiler
Peergroup
© BusinessWire
08.05.2025
HIMS
LISTED
NYSE
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare
News Preview
Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS) today announced its intention to offer, subject to market and other conditions, $450 million aggregate principal amount of convertible senior notes due 2030 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant t...
Themefolio
Profiler
Peergroup
© BusinessWire
08.05.2025
HIMS
LISTED
NYSE
Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer
News Preview
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Mo Elshenawy, a proven technology executive with deep expertise in artificial intelligence and large-scale infrastructure, as the company’s new Chief Technology Officer. His appointment marks a key milestone as Hims & Hers ac...
Themefolio
Profiler
Peergroup
© BusinessWire
05.05.2025
HIMS
LISTED
NYSE
Hims & Hers Health, Inc. Reports First Quarter 2025 Financial Results
News Preview
Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the first quarter ended March 31, 2025, in a shareholder letter that is posted at investors.hims.com.
“We’re starting 2025 with incredible momentum. Millions of people are turning to us for...
Themefolio
Profiler
Peergroup
© BusinessWire
05.05.2025
HIMS
LISTED
NYSE
Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer
News Preview
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Nader Kabbani as Chief Operations Officer.1 A seasoned executive known for scaling trusted consumer and healthcare logistics businesses, Kabbani will oversee operations as the company expands access to personalized care for milli...
Themefolio
Profiler
Peergroup
© BusinessWire
29.04.2025
HIMS
LISTED
NYSE
Hims & Hers and Novo Nordisk Team Up to Expand Affordable Access to Care
News Preview
Novo Nordisk and Hims & Hers Health, Inc. (NYSE: HIMS) today announced a long-term collaboration designed to make proven obesity care and treatments more accessible, more affordable, and more connected for millions of Americans.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202504299...
Themefolio
Profiler
Peergroup
© BusinessWire
14.04.2025
HIMS
LISTED
NYSE
Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025
News Preview
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report first quarter 2025 financial results after the market closes on Monday, May 5, 2025. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.
The conference call can b...
Themefolio
Profiler
Peergroup
© BusinessWire
24.02.2025
HIMS
LISTED
NYSE
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
News Preview
Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the fourth quarter and full year ended December 31, 2024 in a shareholder letter that is posted at investors.hims.com.
“2024 was a fantastic year at Hims and Hers as we continue to build a...
Themefolio
Profiler
Peergroup
© BusinessWire
21.02.2025
HIMS
LISTED
NYSE
Hims & Hers Acquires US-based Peptide Facility
News Preview
Hims & Hers Health, Inc., the leading health and wellness platform, today announced an acquisition that will further verticalize the company’s long-term ability to deliver personalized medications. The company has acquired a US-based peptide facility based in California. The acquisition will enable the company to strengthen the long-term durab...
Themefolio
Profiler
Peergroup
© BusinessWire
19.02.2025
HIMS
LISTED
NYSE
Hims & Hers Acquires At-Home Lab Testing Facility, Expanding Capabilities to Ultimately Include Affordable Whole Body Testing for Subscribers
News Preview
Hims & Hers Health, Inc., the leading health and wellness platform, today announced its plans to introduce at-home lab testing through its platform. The new capability will empower customers to take control of their health with deeper insights and enable providers to access a breadth of data and biomarkers that can help identify risk of diseas...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2025
HIMS
LISTED
NYSE
Hims & Hers Launches Health Collective and Community Member Council
News Preview
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced two new programs dedicated to serving its customers in even more personalized ways, encouraging customers to play an active role in the decisions and choices that shape their healthcare experience.
This press release features mu...
Themefolio
Profiler
Peergroup
© BusinessWire
03.02.2025
HIMS
LISTED
NYSE
Hims & Hers to Announce Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025
News Preview
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report fourth quarter and full year 2024 financial results after the market closes on Monday, February 24, 2025. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.
The...
Themefolio
Profiler
Peergroup
© BusinessWire
12.12.2024
HIMS
LISTED
NYSE
The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight
News Preview
For most Americans, weight is more than just a number. It shapes our health, our mood, our confidence, our spending, and the decisions we make in our day to day lives. In fact, 75% of us think about our weight every single day, and 14% say it’s constantly on our minds.
This press release features multimedia. View the full release here: https://ww...
Themefolio
Profiler
Peergroup
© BusinessWire
03.12.2024
HIMS
LISTED
NYSE
Hims & Hers Named to Inc.’s 2024 Best in Business List in Health Products Category
News Preview
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, is proud to announce its inclusion on the Inc. 2024 Best in Business list in the Health Products category. Inc.’s annual Best in Business Awards celebrate the exceptional achievements and contributions of companies that have made a profound impa...
Themefolio
Profiler
Peergroup
© BusinessWire
21.11.2024
HIMS
LISTED
NYSE
Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys
News Preview
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that Hims & Hers customers will now be able to supplement their treatment plan with daily meal replacement bars and shakes to support them on their comprehensive weight loss journey.
This press release features multimedia. V...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
